The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price Delivery Order contract worth $7,759.71 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,566,640,575 units of Ondansetron ODT 4 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA Troop Support Medical division for a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has a performance period extending through December 31, 2025, and this specific delivery order has a completion date of December 9, 2024. The contract was awarded on December 6, 2024 and did not utilize a set-aside designation.
Generated 3/7/25, 10:01 AM